Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China
Authors:
Open Access
- 22 February 2022
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-14
Abstract
Background: Non-diabetic coronary artery disease (CAD) patients are thought to encounter metabolic dysfunction and while these changes may be imperceptible to the patient they probably influence outcomes. At present, there is no system to support patientssensingthese subtle changes, nor is there an established model for prognoses. The Atherogenic Index of Plasma (AIP) index has already proven useful for atherosclerosis although further research is needed, especially for those without hyperglycemia.Methods: This is a prospective study of 5538 non-diabetic CAD patients who had received percutaneous coronary intervention (PCI). Participants were assigned to one of three groups according to their AIP index. High AIP index cases were then compared to low index patients according to major adverse cardiac events (MACE). Restricted cubic spline (RCS) analysis was also conducted to investigate interrelations between AIP index levels and hazard ratios (HR) for MACEs.Results: Patients with a high AIP index encountered metabolic dysfunction compared to those with a low AIP index i.e., higher Body Mass Index (BMI), Total Cholesterol (TC), Triglycerides (TG), and uric acid as well as lower HDL-C. Each of the aforementioned interrelations were significant withpvalues of less than 0.001. There was also a significant increase in the number of MACEs in the high AIP index group compared to the low AIP index group (HR: 1.37, 95% CI 1.04–1.81;p = 0.025). A J-shaped RCS curve highlighted a change in the HR after the 0.18 juncture (HR per SD: 1.20, 95% CI 0.96–1.50). Further subgroup analysis supported the main findings, all with HRs greater than one.Conclusion: The AIP index could be used in prognostics for non-diabetic CAD patients 2 years after PCI. The relationship between hazard ratio and the AIP index appears to be J-shaped. Although, further multi-center studies designed for non-diabetic patients with potential metabolic dysfunction should be conducted to determine the value of the AIP index.Keywords
Funding Information
- National Natural Science Foundation of China (81825003, 91957123, 81800327, 81900272)
- National Key R&D Program of China (2020YFC2004700)
- Beijing Nova Program (Z201100006820002)
- Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences (2021RU003)
This publication has 47 references indexed in Scilit:
- Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: Lessons from HORIZONS-AMIAmerican Heart Journal, 2015
- Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitusPrimary Care Diabetes, 2015
- Heart Disease and Stroke Statistics—2015 UpdateCirculation, 2015
- Revascularization of Chronic Total OcclusionsJACC, 2014
- Third universal definition of myocardial infarction: Update, caveats, differential diagnosesCleveland Clinic Journal of Medicine, 2013
- Outcomes After Complete Versus Incomplete Revascularization of Patients With Multivessel Coronary Artery DiseaseJACC, 2013
- Atherosclerosis: current pathogenesis and therapeutic optionsNature Medicine, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Current Smoking, Smoking Cessation, and the Risk of Sudden Cardiac Death in Patients With Coronary Artery DiseaseArchives of internal medicine (1960), 2003
- The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL)Clinical Biochemistry, 2001